TABLE 3.

miRNAs expressed by HSV-1 and HSV-2 in productive and latent infections

miRNA	miRNA expression during infection witha:				Alternative name	Reference(s)
	HSV-1		HSV-2
	Productive	Latent	Productive	Latent
H1	+	+	NH	NH		15, 64
H2	+	+	+	+	HSV-2 miR-III	58, 64-66
H3	+	+	+	+	HSV-2 miR-I	57, 58, 64-66
H4	+	+	+	+	HSV-2 miR-II	57, 58, 64-66
H5	+	+	+	+	#4	15, 64, 65
H6	+	+	+	+		64, 65
H7	+	+	+	+	NNb	49, 65, 66
H8	+	+	NH	NH	T-1 (NV)c	15, 49, 65
H9	NH	NH	+	−	T-7 (NV)	15, 49, 65, 66
H10	NH	NH	−	−		66
H11	+	−	+	−	T-4 (NV)	15, 49, 65
H12	+	−	+	−	#6RC (NV)	15
H13	+	−	+	−	#6 (NV)	15
H14	+	−	NH	NH
H15	+	−	NH	NH
H16	+	−	NH	NH
H17	+	+	NH	NH
H18	−	+	NH	NH
H19	NH	NH	+	−	NN, NV	49
H20	NH	NH	+	−	NN, NV	49
H21	NH	NH	+	−
H22	NH	NH	+	−
H23	NH	NH	+	−
H24	NH	NH	+	+
H25	NH	NH	+	−

^amiRNA was detected (+) or not detected (−) in a productively or latently infected sample. NH, no homolog (HSV-1 or HSV-2 does not encode an miRNA homolog).

^bNN, not named. miRNA has been predicted, but a specific name has not been designated.

^cNV, not verified. miRNA has been predicted but not previously experimentally verified.